Becoming Endemic: Anaplasmosis Imported Across State Borders
Joseph D Abraham, Heather S Wenning, Daniyal A Saeed, Armo Derbarsegian, Barry A Brook, Peimei He

TL;DR
An elderly woman in Ohio was diagnosed with tick-borne anaplasmosis after showing symptoms following outdoor exposure in Pennsylvania.
Contribution
This case highlights the importance of early recognition of human granulocytic anaplasmosis for better patient outcomes.
Findings
The patient showed rapid symptom resolution after treatment for HGA.
Early recognition of HGA can reduce unnecessary treatments.
Clinical presentation included leukopenia, thrombocytopenia, and elevated liver enzymes.
Abstract
Anaplasma phagocytophilum is the causative agent of human granulocytic anaplasmosis (HGA), a tick-borne illness with increasing incidence since being described in the 1990s. Importantly, the presentation can be vague, yet prompt treatment is paramount. An 81-year-old Caucasian female was hospitalized in Cincinnati, Ohio, for fever and confusion following prolonged outdoor exposure in Emlenton, Pennsylvania. She initially was treated for sepsis from presumed community-acquired pneumonia; however, the combination of leukopenia, thrombocytopenia, and elevated liver enzymes prompted empiric tick-borne illness consideration and treatment with rapid resolution in symptoms. Early recognition of HGA can reduce unnecessary treatments and improve patient outcomes.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Parameter | Result | Reference Range |
| White blood cell count | 3.3 K/uL | 4.0 - 11.0 K/uL |
| Platelet count | 29 K/uL | 135 - 450 K/uL |
| Alanine transaminase (ALT) | 126 U/L | 10 - 40 U/L |
| Aspartate aminotransferase (AST) | 214 U/L | 15 - 37 U/L |
| Lipase | 138.0 U/L | 13.0 - 60.0 U/L |
| Serum sodium | 130 mmol/L | 136 - 145 mmol/L |
| Serum potassium | 2.6 mmol/L | 3.5 - 5.1 mmol/L |
| Serum chloride | 85 mmol/L | 99 - 110 mmol/L |
| Blood urea nitrogen | 40 mg/dL | 7 - 20 mg/dL |
| Serum creatinine | 1.7 mg/dL | 0.6 - 1.2 mg/dL |
| Estimated glomerular filtration rate | 30 mL/min/1.73 m2 | > 60 mL/min/1.73 m2 |
| Parameter | Result | Reference Range |
| D-dimer | > 20 ug/mL FEU | 0.00 - 0.60 ug/mL FEU |
| Fibrinogen | 274 mg/dL | 243 - 550 mg/dL |
| Collagen/epinephrine closure | > 300 sec | 86 -194 sec |
| Collagen/adenosine 5’ diphosphate time | > 219 sec | 56 -110 sec |
| Lactate dehydrogenase (LDH) | 753 U/L | 100 - 190 U/L |
| Lactic acid | 2.5 mmol/L | 0.4 - 2.0 mmol/L |
| Procalcitonin | 3.27 ng/mL | 0.00 - 0.15 ng/mL |
| Total creatinine kinase | 519 U/L | 26 -192 U/L |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVector-borne infectious diseases · Dermatological diseases and infestations · Viral Infections and Vectors
Introduction
Human granulocytic anaplasmosis (HGA) is caused by the Gram-negative intracellular bacteria Anaplasma phagocytophilum [1]. HGA, formerly known as human granulocytic ehrlichiosis, is transmitted by the *Ixodes scapularis *tick and is commonly reported in the Midwest and the Northeast United States, with most cases occurring in June and July [2,3].
Anaplasmosis typically presents with non-specific symptoms, including fever, malaise, myalgia, arthralgia, headache, and general gastrointestinal symptoms, after one to two weeks [4]. Rarely, it may present with rash or nervous system involvement. Laboratory abnormalities include leukopenia, thrombocytopenia, elevated liver enzymes, and elevated serum creatinine. Peripheral blood smear may reveal morulae, which are intracytoplasmic aggregates within neutrophils [5]. Severe illness is rare but may cause renal or respiratory failure, peripheral neuropathy, coagulopathy, rhabdomyolysis, hemorrhage, or hemophagocytic lymphohistiocytosis [6]. First-line treatment is doxycycline [7].
This is an imported case of HGA that was initially treated as community-acquired pneumonia. Careful consideration of patient history and laboratory analysis led to tick-borne illness consideration and diagnosis in an HGA non-prevalent region.
Case presentation
An 81-year-old Caucasian female presented to the hospital with new-onset confusion. Prior to her arrival, she spent a week in Emlenton, Pennsylvania, in a cabin with her husband. Symptoms started four days before admission consisting of fever, fatigue, headache, myalgias, diffuse joint pain, emesis, and non-bloody diarrhea. She reported a fever of 104.1°F one day prior to presentation. There were no known animal contacts, tick bites, or sick contacts.
On presentation, the patient was afebrile, hemodynamically stable, somnolent, and only oriented to self. Her physical examination was notable for diminished bilateral breath sounds with left-sided rales and abdominal distention; no dermatologic abnormalities were identified.
Her laboratory workup in the emergency department (ED) revealed leukocytopenia, thrombocytopenia, elevated liver enzymes, and acute kidney injury (AKI) (Table 1).
Chest X-ray and abdominopelvic computed tomography scan with intravenous contrast were unremarkable. COVID-19, influenzae A and B, a hepatitis panel, a bacterial gastrointestinal panel, and *Clostridium difficile *antigen/toxin testing were negative. A 2 L intravenous (IV) lactated Ringer’s bolus and subsequent infusion of normal saline were given. Blood and urine cultures were ordered, and empiric treatment with ceftriaxone and azithromycin was initiated for presumed community-acquired pneumonia.
Once admitted, labs revealed persistently elevated liver function enzymes, thrombocytopenia, and leukopenia. Additionally, lactic acid, procalcitonin, and creatinine kinase were elevated (Table 2). Infectious Disease was consulted to entertain the possibility of a tick-borne illness. The patient was transitioned to doxycycline 100 mg IV twice daily and cefepime to cover tick-borne illness and community-acquired pneumonia. Testing for tick-borne diseases was ordered with a peripheral blood smear review. Due to severe thrombocytopenia, with a platelet nadir of 15 K/uL, additional labs were ordered (Table 2), and she received one unit of platelets, doubling her count to 30 K/uL.
On hospital day one, the peripheral blood smear was unremarkable for morulae. Overnight, the patient developed acute hypoxic respiratory failure, requiring oxygen via a non-rebreather mask. Repeat chest X-ray showed suspected mild interstitial edema, attributable to hypervolemia from fluids administered. She was shortly weaned off oxygen by morning. A bilateral lower extremity ultrasound venous duplex showed no evidence of deep vein thrombosis.
On hospital day two, her vitals and platelets remained stable, her AKI resolved, and her liver enzymes were improving. Her blood and urine cultures remained sterile. She was discharged with oral doxycycline.
After discharge, the polymerase chain reaction confirmed the presence of A. phagocytophilum. Borrelia burgdorferi testing showed prior infection with positive IgG and negative IgM.
At follow-up, testing showed a normal platelet count of 347 K/uL, stable renal function, and continued improvement in transaminases with ALT 98 U/L and AST 58 U/L.
Discussion
Incidence of anaplasmosis has steadily increased in the United States according to the CDC [3]. This reported case is a part of that trend, but awareness needs to be spread to non-endemic areas. Ohio had zero reported cases of anaplasmosis from January through June 22nd of 2023 and 11 cases in all of 2022 [8]. Symptoms begin one to two weeks after infection, meaning physicians should be aware of imported cases from endemic areas and what early signs and laboratory studies could indicate tick-borne illnesses [9].
A retrospective chart review study from Hershey Medical Center found human granulocytic anaplasmosis infections in Pennsylvania rapidly rose from 2008 through 2021. They noted 61 cases at Hershey Medical Center alone over that time span, with the first case in 2013 and then a rapid rise from 2017 onward. By looking at the Pennsylvania Department of Health (DOH) data, they found cases were spreading geographically, with explosions in numbers in Eastern, Central, and Western counties of Pennsylvania. Less than 10 cases were reported in 2012 to the Pennsylvania DOH, while in 2021, there were more than 600 cases reported [9].
Similarities to this reported case were found in the Hershey Medical Center data of 61 patients. Of the reported cases, 75.4% were in those greater than 60 years of age. While only 39% recalled a tick bite, about 80% reported outdoor activity, which was the highest reported risk factor. Their most commonly presenting symptom was subjective fever (85%), which was a chief complaint for our patient. The study reported elevated liver enzymes and thrombocytopenia as common laboratory manifestations (71% and 69% of patients, respectively), and less often (27%) leukopenia, all three were seen in our patient [9]. Early empiric treatment is vitally important, as HGA can be deadly if untreated or if treatment is delayed. A systemic review of published cases identified 110 patients with HGA, in which six patients died. Of those six, two did not receive appropriate antibiotics, and another two did not receive them within the first 48 hours [10].
The Alleghany Public Health Department’s data revealed an uptick in county cases. From 2011 to 2020, they had a total of 27 cases, with zero cases in 2013 and 2015. Every year since 2018, the number of cases has been rising, with double-digit cases first starting in 2020 at a count of 13. Additionally, 2021 had 20 cases, 2022 had 33 cases, more than their 2011-2020 years combined. This seemingly compounding trend demonstrates the need for increased awareness of HGA amongst physicians as it is possibly now endemic or will be in the near future [11].
Other, more prevalent diseases, such as COVID-19 infection, can cause similar manifestations [12], making subjective and objective findings increasingly important. While anaplasmosis presents with a rash a minority of the time, it can present as a co-infection with other tick-borne diseases that frequently do, such as Lyme disease (LD) [10]. Using erythema migrans, the classic Bull’s-eye pattern rash from LD, to enroll patients from 1995 through 2004 in Valhalla, New York, one study found co-infection rates with HGA to be 2.3-10.0%, depending on the laboratory definition of a positive HGA infection [13]. Another study in Western Ukraine examined 498 patients from 2006 through 2014 who were treated for tick-borne illnesses, 60 of whom were diagnosed with HGA. Of those 60, 28 patients also had LD, equating to a HGA-LD co-infection rate of 46.7% (± 6.4%) [14].
Conclusions
Due to the vague presentation, it is important to include human granulocytic anaplasmosis and other tick-borne diseases in a wide differential. Thrombocytopenia, leukopenia, and elevated liver enzymes should raise suspicion of a tick-borne etiology, even when not in endemic regions. This is becoming more important given the increase in areas and rates of the disease. Additionally, this could reduce diagnosis time and improve treatment outcomes when earlier intervention is initiated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Human granulocytic anaplasmosis and Anaplasma phagocytophilum Emerg Infect Dis Dumler JS Choi KS Garcia-Garcia JC 182818341120051648546610.3201/eid 1112.050898 PMC 3367650 · doi ↗ · pubmed ↗
- 2The natural history of ticks Med Clin North Am Anderson JF 2052188620021198229810.1016/s 0025-7125(03)00083-x · doi ↗ · pubmed ↗
- 3Anaplasmosis 7 2023 2022 https://www.cdc.gov/anaplasmosis/index.html
- 4Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts Mayo Clin Proc Weil AA Baron EL Brown CM Drapkin MS 2332398720122238617810.1016/j.mayocp.2011.09.008PMC 3498394 · doi ↗ · pubmed ↗
- 5Clinical and laboratory characteristics of human granulocytic ehrlichiosis JAMA Bakken JS Krueth J Wilson-Nordskog C Tilden RL Asanovich K Dumler JS 1992052751996 https://pubmed.ncbi.nlm.nih.gov/8604172/8604172 · pubmed ↗
- 6Anaplasmosis-induced hemophagocytic lymphohistiocytosis Proc (Bayl Univ Med Cent) de Jesus M Lopez A Yabut J Vu S Manne M Ibrahim L Mutneja R 3793813520223551881410.1080/08998280.2022.2039046 PMC 9037399 · doi ↗ · pubmed ↗
- 7The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America Clin Infect Dis Wormser GP Dattwyler RJ Shapiro ED 108911344320061702913010.1086/508667 · doi ↗ · pubmed ↗
- 8Ohio vectorborne disease surveillance update 7 2023 2019 https://u.osu.edu/zika/2019/07/10/ohio-vectorborne-disease-surveillance-update/
